Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7858974rdf:typepubmed:Citationlld:pubmed
pubmed-article:7858974lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0220806lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0017082lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0041365lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0061099lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:7858974lifeskim:mentionsumls-concept:C1518422lld:lifeskim
pubmed-article:7858974pubmed:issue7lld:pubmed
pubmed-article:7858974pubmed:dateCreated1995-3-20lld:pubmed
pubmed-article:7858974pubmed:abstractTextN-Glycolylglucosamine 8 was synthesized in 4 steps from anisal glucosamine, via the new crystalline monochloracetyl derivatives 3, 4 and 7. N-Glycolylneuraminic acid 10 was prepared in 59% yield starting from pyruvate and a mixture of 8 and its manno epimer 9 in a 2:3 ratio, with immobilized sialic acid aldolase. Neu5Gc 10 was converted into CMP-NeuGc 11 in the presence of immobilized calf brain CMP-sialate synthetase. Finally 11 was used as a donor in the transfer to the acceptor beta-D-Gal-(1-3)-beta-D-GalNAc-OBn 12 catalyzed by a preparation of porcine liver (2-3)-alpha-sialyltransferase, roughly purified by a chromatography on Cibacron Blue-agarose. alpha-Neu5Gc-(2-3)-beta-D-Gal-(1-3)-beta-D-GalNac-OBn 13 isolated in 56% yield was deprotected to give the non-reducing terminal sequence of GM1b glycolylated ganglioside, which might be expressed in human tumors.lld:pubmed
pubmed-article:7858974pubmed:languageenglld:pubmed
pubmed-article:7858974pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:citationSubsetIMlld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7858974pubmed:statusMEDLINElld:pubmed
pubmed-article:7858974pubmed:monthJullld:pubmed
pubmed-article:7858974pubmed:issn0968-0896lld:pubmed
pubmed-article:7858974pubmed:authorpubmed-author:AugéCClld:pubmed
pubmed-article:7858974pubmed:authorpubmed-author:LubineauAAlld:pubmed
pubmed-article:7858974pubmed:authorpubmed-author:Gautheron-Le...lld:pubmed
pubmed-article:7858974pubmed:authorpubmed-author:GinetJ CJClld:pubmed
pubmed-article:7858974pubmed:issnTypePrintlld:pubmed
pubmed-article:7858974pubmed:volume2lld:pubmed
pubmed-article:7858974pubmed:ownerNLMlld:pubmed
pubmed-article:7858974pubmed:authorsCompleteYlld:pubmed
pubmed-article:7858974pubmed:pagination669-74lld:pubmed
pubmed-article:7858974pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:meshHeadingpubmed-meshheading:7858974-...lld:pubmed
pubmed-article:7858974pubmed:year1994lld:pubmed
pubmed-article:7858974pubmed:articleTitleCombined chemical and enzymatic synthesis of the sialylated non reducing terminal sequence of GM1b glycolylated ganglioside, a potential human tumor marker.lld:pubmed
pubmed-article:7858974pubmed:affiliationInstitut de Chimie Moléculaire d'Orsay, URA CNRS 462, Université Paris-Sud, Orsay, France.lld:pubmed
pubmed-article:7858974pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7858974lld:pubmed